PI
SUPN icon

PineBridge Investments’s Supernus Pharmaceuticals SUPN Stock Holding History

PineBridge Investments’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-31,298
Closed -$743K – 997
2019
Q4 		$743K Sell
31,298
-15,969
-34% -$388K 0.01% 716
2019
Q3 		$1.3M Buy
47,267
+4,087
+9% +$121K 0.02% 620
2019
Q2 		$1.43M Buy
43,180
+29,795
+223% +$1.02M 0.02% 496
2019
Q1 		$469K Buy
13,385
+303
+2% +$11.3K 0.01% 715
2018
Q4 		$434K Buy
13,082
+2,113
+19% +$90.9K 0.01% 720
2018
Q3 		$552K Buy
10,969
+2,473
+29% +$122K 0.01% 726
2018
Q2 		$509K Sell
8,496
-446
-5% -$23.1K 0.01% 695
2018
Q1 		$410K Sell
8,942
-10,251
-53% -$428K 0.01% 725
2017
Q4 		$765K Buy
19,193
+12,901
+205% +$510K 0.02% 662
2017
Q3 		$252K Sell
6,292
-332
-5% -$14.4K 0.01% 795
2017
Q2 		$285K Buy
6,624
+86
+1% +$3.06K 0.01% 735
2017
Q1 		$205K Buy
6,538
+243
+4% +$6.51K 0.01% 794
2016
Q4 		$159K Hold
6,295
– – ﹤0.01% 884
2016
Q3 		$155K Buy
6,295
+1,907
+43% +$43.2K 0.01% 609
2016
Q2 		$89K Buy
4,388
+364
+9% +$6.46K ﹤0.01% 812
2016
Q1 		$61K Sell
4,024
-572
-12% -$7.46K ﹤0.01% 875
2015
Q4 		$62K Buy
4,596
+1,005
+28% +$15.5K ﹤0.01% 898
2015
Q3 		$51K Buy
3,591
+332
+10% +$6.17K ﹤0.01% 929
2015
Q2 		$56K Buy
+3,259
New +$46.4K ﹤0.01% 924

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PineBridge Investments's SUPN Position: Q1 2020 in Review

PineBridge Investments sold out of Supernus Pharmaceuticals (SUPN) in Q1 2020, closing a stake of 31,298 shares — an estimated $743K sold.

PineBridge Investments first reported a position in SUPN in Q2 2015 and held it in 19 quarters. The position peaked at $1.43M in Q2 2019. 208 funds tracked by Wall St. Rank hold SUPN as of Q1 2020.

  • PineBridge Investments reported no remaining Supernus Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • PineBridge Investments sold 31,298 Supernus Pharmaceuticals shares in Q1 2020, an estimated $743K.
  • PineBridge Investments first reported a position in Supernus Pharmaceuticals in Q2 2015 and held it in 19 quarters.
  • PineBridge Investments's Supernus Pharmaceuticals position peaked at $1.43M in Q2 2019.
  • 208 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2020.

Based on PineBridge Investments's 13F filing for Q1 2020, filed 14 May 2020.